Chemistry: molecular biology and microbiology – Vector – per se
Patent
1992-02-05
1995-06-06
Elliott, George C.
Chemistry: molecular biology and microbiology
Vector, per se
4351723, 435 694, 435 696, 53038835, 536 231, 4241881, 4242081, C12N 1500, A61K 3900, C07K 300
Patent
active
054222745
ABSTRACT:
This invention provides a therapeutic agent capable of specifically forming a complex with human immunodeficiency virus envelope glycoprotein which comprises a polypeptide. In one embodiment of the invention, the amino acid sequence of the polypeptide has the amino acid sequence shown in FIG. 6 from about +1 to about +185 fused to the amino acid sequence from about +353 to about +371. In another embodiment of the invention, the amino acid sequence of the polypeptide has the amino acid sequence shown in FIG. 6 from about +1 to about +106 fused to the amino acid sequence from about +353 to about +371. In yet a further embodiment of the invention, the amino acid sequence of the polypeptide has the amino acid sequence shown in FIG. 6 from about +1 to about +185.
This invention also provides a method for treating a subject infected with a human immunodeficiency virus. The method treats the subject with an effective amount of a pharmaceutical composition having an effective amount of a therapeutic agent of the invention and a pharmaceutically acceptable carrier.
REFERENCES:
patent: 4520113 (1985-05-01), Gallo et al.
patent: 4621054 (1986-11-01), Suzuki et al.
patent: 4629783 (1986-12-01), Cosand
patent: 4663436 (1987-05-01), Elder et al.
patent: 5109123 (1992-04-01), Reinhirz et al.
Maddon et al. Cell(1985) 42:93-104 The isolation and Nucleotide Sequence of . . . T4.
Littman, D. R., et al., Chemical Abstracts, vol. 103, p. 175, column 1, abstract no. 190783 (U.S.A., 1985).
Maddon, P. J. et al., Cell, vol. 42, pp. 93-104 (U.S.A., 1985).
Maddon, P. J. et al., Cell, vol. 47, pp. 333-348 (U.S.A., 1986).
McDougal, J. S., et al., J. of Immunology, pp. 2937-2944 (U.S.A., 1986).
Isobe, M., et al., Proc Natl. Acad. Sci. USA, vol. 83, pp. 4399-4402 (U.S.A., 1986).
McDougal, J. S., et al., Science, vol. 231, pp. 382-385 (U.S.A., 1986).
Blue, M., et al., J. of Immunology, vol. 134, pp. 2281-2286 (U.S.A., 1985).
Dalgleish, A. G., et al., Nature, vol. 312, pp. 763-767 (London, 1984).
Ratner, L., et al., Nature, vol. 313, pp. 277-284 (London, 1985).
Wong-Staal, F., et al., Nature, vol. 317, pp. 395-403 (London, 1985).
Klatzmann, D., et al., Nature, vol. 312, pp. 767-768 (London, 1984).
Terhorst, C., et al., Science, vol. 209, pp. 520-521 (U.S.A. 1980).
Arthos James
Axel Richard
Maddon Paul J.
Sweet Raymond W.
Elliott George C.
Nisbet T. Michael
SmithKline Beckman Corporation
The Trustees of Columbia University in the City of New York
White John P.
LandOfFree
Internal deletion mutants of soluble T4(CD4) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Internal deletion mutants of soluble T4(CD4), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Internal deletion mutants of soluble T4(CD4) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-987183